Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-12-012217

EVP, CLO, and Secretary acquired 43,802 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BELBEL CAESAR J EVP, CLO, and Secretary 2012-02-22 Grant or award +43,802 65,380 D
Loading xslF345X03/doc4.xml…